In the last trading session, 28.34 million Clover Health Investments Corp (NASDAQ:CLOV) shares changed hands as the company’s beta touched 2.08. With the company’s per share price at $3.18 changed hands at $0.35 or 12.37% during last session, the market valuation stood at $1.58B. CLOV’s last price was a premium, traded about 8.81% off its 52-week high of $2.90. The share price had its 52-week low at $0.61, which suggests the last value was 80.82% up since then. When we look at Clover Health Investments Corp’s average trading volume, we note the 10-day average is 11.69 million shares, with the 3-month average coming to 5.87 million.
Analysts gave the Clover Health Investments Corp (CLOV) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.33. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended CLOV as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Instantly CLOV was in green as seen at the end of in last trading. With action 70.05%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 234.00%, with the 5-day performance at 70.05% in the green. However, in the 30-day time frame, Clover Health Investments Corp (NASDAQ:CLOV) is 95.09% up. Looking at the short shares, we see there were 32.55 million shares sold at short interest cover period of 8.08 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2.15, meaning bulls need a downside of -47.91% from its current market value. According to analyst projections, CLOV’s forecast low is 1.8 with 2.5 as the target high. To hit the forecast high, the stock’s price needs a 21.38% surge from its current level, while the stock would need to tank 43.4% for it to hit the projected low.
Clover Health Investments Corp (CLOV) estimates and forecasts
Data shows that the Clover Health Investments Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 220.34% over the past 6 months, a 68.29% in annual growth rate that is considerably higher than the industry average of 18.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -585.84%. The 2024 estimates are for Clover Health Investments Corp earnings to increase by 71.11%, but the outlook for the next 5-year period is at 19.10% per year.
CLOV Dividends
Clover Health Investments Corp is expected to release its next quarterly earnings report in September.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 9.09% of Clover Health Investments Corp shares while 18.56% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 20.41%. There are 18.56% institutions holding the Clover Health Investments Corp stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-03-31, the company held 3.6749% of the shares, roughly 17.7 million CLOV shares worth $14.05 million.
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 2.3664% or 11.4 million shares worth $9.05 million as of 2024-03-31.
